Skip to main content
ABEO logo

ABEO · Abeona Therapeutics Inc. · Webcasts, Transcripts & Audio

Track ABEO — free
$4.45 +0.14 (+3.25%) At close · Oct 27 Q1 2026 earnings call transcript
Market Cap
$255.33M
Shares
57.18M
Volume · Oct 27 663.68K Avg daily vol (3M) 1.36M

Abeona Therapeutics Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Abeona Therapeutics Inc. (ABEO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-09-16
Abeona Therapeutics Inc. (ABEO) September 16, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-13
Abeona Therapeutics Inc. (ABEO) Q2 2026 Earnings Call
Revenue
$11.38M
▲ 2745% YoY
Diluted EPS
$-0.35
▼ 120.5% YoY
Gross margin
63.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-04
Abeona Therapeutics Inc. (ABEO) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-13
Abeona Therapeutics Inc. (ABEO) Q1 2026 Earnings Call Transcript
Confident tone ZivaSkin Commercial Launch Patient Demand and Referrals QTC Activation and Expansion
Revenue
$8.72M
Diluted EPS
$-0.30
Gross margin
69.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call Transcript
Positive tone ZivaSkin commercial launch execution Qualified Treatment Center (QTC) expansion Payer coverage and market access
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript
Positive tone ZivaSkin commercial launch progress Qualified treatment center (QTC) network expansion Patient identification and demand
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-02
Abeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call Transcript
Confident tone ZEVASKYN FDA approval and commercial launch Patient demand and QTC activation Payer coverage and reimbursement
Revenue
$400,000
Diluted EPS
$1.71
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript
Confident tone Patient demand and Abeona Assist ZEVASKYN FDA approval and commercial launch Qualified Treatment Centers and patient activation
Diluted EPS
$-0.24
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Abeona Therapeutics Inc. (ABEO) Q4 2024 Earnings Call Transcript
Confident tone Launch readiness and qualified treatment centers pz-cel PDUFA and FDA approval PRV (Priority Review Voucher)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Abeona Therapeutics Inc. (ABEO) Q3 2024 Earnings Call
Diluted EPS
$-0.63
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Abeona Therapeutics Inc. (ABEO) Q2 2024 Earnings Call
Diluted EPS
$-0.26
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
Abeona Therapeutics Inc. (ABEO) Q1 2024 Earnings Call
Diluted EPS
$-1.16
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-18
Abeona Therapeutics Inc. (ABEO) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Abeona Therapeutics Inc. (ABEO) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.48
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Abeona Therapeutics Inc. (ABEO) Q2 2023 Earnings Call Transcript
Revenue
$3.50M
▲ 250% YoY
Diluted EPS
$-0.92
▼ 167.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Abeona Therapeutics Inc. (ABEO) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.54
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
Abeona Therapeutics Inc. (ABEO) Q4 2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-08-11
Abeona Therapeutics Inc. (ABEO) Q2 2022 Earnings Call Transcript
Revenue
$1.00M
Diluted EPS
$1.36
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-13
Abeona Therapeutics Inc. (ABEO) Q1 2022 Earnings Call Transcript
Revenue
$346,000
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-31
Abeona Therapeutics Inc. (ABEO) Q4 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-15
Abeona Therapeutics Inc. (ABEO) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Abeona Therapeutics Inc. (ABEO) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-18
Abeona Therapeutics Inc. (ABEO) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-24
Abeona Therapeutics Inc. (ABEO) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Abeona Therapeutics Inc. (ABEO) Q3 2020 Earnings Call Transcript
Revenue
$7.00M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Abeona Therapeutics Inc. (ABEO) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Abeona Therapeutics Inc. (ABEO) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-16
Abeona Therapeutics Inc. (ABEO) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 webcasts
Key facts CIK 318306 CUSIP 00289Y206 13F (30d) 15 filings 15 filers Visit website Investor relations